About PolyPid Ltd.
We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes.
PolyPid Ltd. (PYPD) Stock Score & Signals
PolyPid Ltd. (PYPD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry. Its current 2BB score is 28 out of 100.
2BB score and signals
PolyPid Ltd.’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 18 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 65 | High (provisional) |
Company facts
| Founded | 2008 |
| Employees | 72 |
| 52-week range | $3.50 – $6.14 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-09 | — | -0.4136 | — | $0.00 |
| 2026-11-11 | — | 0.0588 | — | $18.36M |